Edition:
India

People: Charles River Laboratories International Inc (CRL.N)

CRL.N on New York Stock Exchange

237.42USD
4 Dec 2020
Change (% chg)

$2.43 (+1.03%)
Prev Close
$234.99
Open
$235.26
Day's High
$238.11
Day's Low
$235.26
Volume
80,895
Avg. Vol
84,200
52-wk High
$256.96
52-wk Low
$95.79

Mangeolle, Jean-Paul 

Mr. Jean-Paul Mangeolle is Independent Director of the company. Mr. Mangeolle serves on the Board of Gelest, a New Mountain Capital company. He was the President of Sciex, a group composed of ABSciex and Phomonenex, two operating companies of Danaher, from July 2014 to September 2017. He was Executive Vice President of Merck KGaA from July 2010 to July 2012 and President at Millipore from July 2005 to July 2010. Mr. Mangeolle's extensive experience leading global life science and bioscience companies, with a specific focus on high-end instrumentation, provides us with a unique combination of expertise particular to our Manufacturing Support business segment. Mr. Mangeolle has been a director since January 2018.

Basic Compensation

Total Annual Compensation, USD 65,000
Restricted Stock Award, USD 243,606
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 308,606

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

James Foster

17,722,100

David Smith

3,507,300

William Barbo

2,576,390

Birgit Girshick

2,988,000

Joseph LaPlume

3,009,510

George Milne

344,856
As Of  28 Dec 2019